Dose escalation for prostate stereotactic ablative radiotherapy (SABR): late outcomes from two prospective clinical trials

Y Alayed, P Cheung, G Pang, A Mamedov… - Radiotherapy and …, 2018 - Elsevier
Purpose Optimal prostate SABR dose-fractionation is unknown. This study compares long-
term outcomes from two prospective trials. Methods Study1 patients had low-risk PCa and …

[HTML][HTML] Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016)

JN Staffurth, JS Haviland, A Wilkins, I Syndikus… - European urology …, 2021 - Elsevier
Background Moderate hypofractionation is the recommended standard of care for localised
prostate cancer following the results of trials including Conventional or Hypofractionated …

Hypofractionated radiotherapy for localized prostate cancer.

S Höcht, DM Aebersold, C Albrecht… - Strahlentherapie und …, 2017 - boris.unibe.ch
AIM This article gives an overview on the current status of hypofractionated radiotherapy in
the treatment of prostate cancer with a special focus on the applicability in routine use …

[HTML][HTML] HERMES: Delivery of a speedy prostate cancer treatment

R Westley, E Hall, A Tree - Clinical Oncology (Royal College of …, 2022 - ncbi.nlm.nih.gov
The burden on the National Health Service is more pronounced than ever and there remains
a pressing need to reduce the number of patient visits where possible. Not only has the …

[HTML][HTML] Single-fraction stereotactic body radiation therapy: a paradigm during the coronavirus disease 2019 (COVID-19) pandemic and beyond?

SSW Ng, MS Ning, P Lee, RA McMahon, S Siva… - Advances in Radiation …, 2020 - Elsevier
Purpose Owing to the coronavirus disease 2019 (COVID-19) pandemic, radiation oncology
departments have adopted various strategies to deliver radiation therapy safely and …

Conventional versus hypofractionated radiation therapy for localized prostate cancer: a meta-analysis of randomized noninferiority trials

TJ Royce, DH Lee, NN Keum, N Permpalung… - European urology …, 2019 - Elsevier
Context Whether hypofractionated radiation therapy (RT) compared with conventionally
fractionated RT provides comparable or possibly improved cancer control without increased …

Recommandations en onco-urologie 2016-2018 du CCAFU: Cancer de la prostate

F Rozet, C Hennequin, JB Beauval, P Beuzeboc… - Progrès en urologie, 2016 - Elsevier
Objectives The purpose of the guidelines national committee CCAFU was to propose
updated french guidelines for localized and metastatic prostate cancer (PCa). Methods A …

Optimizing Clinical Implementation of Hypofractionation: Comprehensive Evidence Synthesis and Practical Guidelines for Low-and Middle-Income Settings

MTM Starling, S Thibodeau, CFPM de Sousa… - Cancers, 2024 - mdpi.com
Simple Summary The increasing global cancer burden is intensifying health disparities,
especially in low-and middle-income countries (LMICs), where access to advanced …

Four-year outcomes from a prospective phase II clinical trial of moderately hypofractionated proton therapy for localized prostate cancer

AS Grewal, C Schonewolf, EJ Min, HH Chao… - International Journal of …, 2019 - Elsevier
Purpose Moderately hypofractionated radiation therapy represents an effective treatment for
localized prostate cancer (PC). Although large randomized trials have reported the efficacy …

Health disparities in prostate cancer and approaches to advance equitable care.

C Washington, DA Goldstein, A Moore… - American Society of …, 2022 - europepmc.org
The American Cancer Society estimates approximately 268,490 new cases of prostate
cancer and approximately 34,500 deaths caused by prostate cancer in the United States for …